EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Approaches in Glucose and Lipid Metabolism Disorder Therapy: Targeting the Gut Microbiota–Bile Acid Axis

Jin Jiang, Huange Zhang, Muhammad Hussain, Abdullah, Fengqin Feng iD, Rongfa Guan, Hao Zhong

Biology · 02.07.2025 · 14 (7) · 802

DOI: 10.3390/biology14070802 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 02.07.2025. Verfasst von Jin Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysregulation involving glucose and lipids is closely associated with chronic diseases such as type 2 diabetes mellitus. Emerging evidence highlights the regulatory role of bile acid (BA)–gut microbiota interactions in these metabolic disorders. The gut microbiota orchestrates the biotransformation of primary BAs into bioactive secondary BAs, which function as endocrine signaling molecules by activating the nuclear farnesoid X receptor (FXR) and G protein-coupled membrane receptor (TGR5), forming a communication network essential for metabolic homeostasis. BAs also reciprocally modulate gut microbiota composition. This BA–gut microbiota co-metabolism has emerged as a promising therapeutic target for lipid metabolism disorders. This comprehensive review examines the bidirectional interplay between gut microbiota and BA metabolism, focusing on microbial transformation of BAs, host–microbial co-regulatory pathways and mechanisms of BA metabolism, and the therapeutic implications of modulating the gut microbiota–BA axis in addressing glucose and lipid metabolism disorders. The synthesis of current evidence aims to elucidate the intricate crosstalk between microbial ecology and host metabolism mediated by BA signaling pathways, thereby exploring novel therapeutic intervention strategies.

Schlagwörter

Stichwörter der Autor:innen

FXRTGR5bile acidsglucose and lipid metabolismgut microbiota

Autor:innen und Institutionen

  • College of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
  • College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China.

ORCID-Profile: Fengqin Feng

Förderung

  • National Natural Science Foundation of China
  • "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province
  • Zhejiang Provincial Natural Science Foundation of China
  • Zhejiang University of Technology - Company Crosswise Project
  • “Pioneer” and “Leading Goose” R&D Program of Zhejiang Province
  • Zhejiang University of Technology

Zitieren

APA

Jiang, J., Zhang, H., Hussain, M., Abdullah, Feng, F., Guan, R., & Zhong, H. (2025). Novel Approaches in Glucose and Lipid Metabolism Disorder Therapy: Targeting the Gut Microbiota–Bile Acid Axis. Biology, 14(7), 802. https://doi.org/10.3390/biology14070802

Vancouver

Jiang J, Zhang H, Hussain M, Abdullah, Feng F, Guan R, et al. Novel Approaches in Glucose and Lipid Metabolism Disorder Therapy: Targeting the Gut Microbiota–Bile Acid Axis. Biology. 2025;14(7):802. doi:10.3390/biology14070802

BibTeX
@article{Jiang2025,
  author = {Jiang, Jin and Zhang, Huange and Hussain, Muhammad and Abdullah and Feng, Fengqin and Guan, Rongfa and Zhong, Hao},
  title = {Novel Approaches in Glucose and Lipid Metabolism Disorder Therapy: Targeting the Gut Microbiota–Bile Acid Axis},
  journal = {Biology},
  year = {2025},
  volume = {14},
  number = {7},
  pages = {802},
  doi = {10.3390/biology14070802}
}
Kostenlos starten →